Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: France Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20034
20051
20063
20074
20094
20106
20112
20121
20131
20145
20153
20163
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi8
Novo Nordisk A/S6
AstraZeneca3
Centre Hospitalier Universitaire Dijon3
Eli Lilly and Company2
GlaxoSmithKline2
Janssen Research & Development, LLC2
Novartis2
Assistance Publique - Hôpitaux de Paris1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 241
Diabetes Mellitus13
Insulin Resistance3
Hypertension2
Acquired Immunodeficiency Syndrome1
Albuminuria1
Bites and Stings1
Diabetic Neuropathies1
Hematologic Neoplasms1
Hypergammaglobulinemia1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.